Green Energy Sector Vs Pharma Sector

The main difference between Green Energy Sector and Pharma Sector is that the green energy sector develops sustainable power solutions promoting environmental conservation, while the pharmaceutical sector focuses on drug development and healthcare solutions improving human health and wellness.

Green Energy Sector Overview

The green energy sector encompasses companies specializing in renewable power generation through solar, wind and hydroelectric technologies. These organizations drive environmental sustainability while reducing carbon emissions and promoting energy independence through innovative solutions.

The sector demonstrates continuous advancement in energy technology, improving efficiency and reducing costs. Companies maintain extensive power generation facilities while investing in research and development for sustainable solutions.

Pharma Sector Overview

The pharmaceutical sector comprises companies engaged in drug research, development, manufacturing and distribution. These organizations focus on creating innovative medical solutions addressing various health conditions through scientific advancement.

The sector maintains critical importance through continuous research and development, sophisticated manufacturing processes and stringent quality control systems ensuring safe and effective healthcare products.

Best Stocks In The Green Energy Sector

The below table shows the Best Stocks In The Green Energy Sector based on 1Y return.

Name	Close Price (rs)	1Y Return (%)
Waaree Renewable Technologies Ltd	1015.95	68.83
Inox Wind Ltd	165.57	53.79
Suzlon Energy Ltd	57.43	39.56
K.P. Energy Ltd	456.35	37.53
JSW Energy Ltd	557.55	14.98
Tata Power Company Ltd	365.90	5.69
NHPC Ltd	79.02	4.04
SJVN Ltd	98.90	-4.81
Orient Green Power Company Ltd	16.07	-21.08
Adani Green Energy Ltd	1045.70	-37.79

Top Stocks In The Pharma Sector

The below table shows the Top Stocks In The Pharma Sector based on 1Y return.

Name	Close Price (rs)	1Y Return (%)
Divi’s Laboratories Ltd	5818.90	60.95
Lupin Ltd	2104.25	46.20
Zydus Lifesciences Ltd	985.90	36.53
Sun Pharmaceutical Industries Ltd	1762.70	27.89
Torrent Pharmaceuticals Ltd	3156.30	26.91
Mankind Pharma Ltd	2563.55	19.63
Dr Reddy’s Laboratories Ltd	1288.15	13.51
Alkem Laboratories Ltd	5177.30	7.51
Aurobindo Pharma Ltd	1187.00	4.71
Cipla Ltd	1428.00	1.35

Fundamental Analysis Of Green Energy Sector

Waaree Renewable Technologies Ltd

Waaree Renewable Technologies is an engineering, procurement and construction (EPC) company focused on the renewable energy sector. The company specializes in solar EPC business, offering comprehensive solutions including rooftop solar, floating solar and ground-mounted projects through both CAPEX and RESCO models.

• Market Cap: ₹10,590.93 Cr

• Current Share Price: ₹1,015.95

• Returns: 1Y (68.83%), 1M (-22.87%), 6M (-45.84%)

• 5Y Average Net Profit Margin: -4.14%

• Dividend Yield: 0.10%

• 5Y CAGR: -4.14%

• Sector: Construction & Engineering

Inox Wind Ltd

Inox Wind is an integrated wind energy solutions provider manufacturing wind turbine generators (WTGs). With three manufacturing plants in Gujarat, Himachal Pradesh and Madhya Pradesh, the company has a cumulative manufacturing capacity of 1,600 MW, serving IPPs, utilities, PSUs and corporate clients.

• Market Cap: ₹21,586.92 Cr

• Current Share Price: ₹165.57

• Returns: 1Y (53.79%), 1M (-9.46%), 6M (10.67%)

• 5Y Average Net Profit Margin: -48.96%

• 5Y CAGR: -48.96%

• Sector: Heavy Electrical Equipments

Suzlon Energy Ltd

Suzlon Energy is a global renewable energy solutions provider specializing in wind turbine generators (WTGs). Founded in India, the company operates in 17 countries across multiple continents, offering advanced products like S144, S133 and S120 Wind Turbine Generators, along with comprehensive operations and maintenance services.

• Market Cap: ₹78,380.56 Cr

• Current Share Price: ₹57.43

• Returns: 1Y (39.56%), 1M (-10.63%), 6M (4.27%)

• 5Y Average Net Profit Margin: -9.16%

• 5Y CAGR: -9.16%

• Sector: Renewable Energy Equipment & Services

K.P. Energy Ltd

K.P. Energy specializes in wind farm development and related services in India. The company provides comprehensive solutions from siting wind farms to operations and maintenance, serving equipment manufacturers, independent power producers and institutional investors through three segments: Infrastructure Development, Power Sales and O&M Services.

• Market Cap: ₹3,043.40 Cr

• Current Share Price: ₹456.35

• Returns: 1Y (37.53%), 1M (-14.54%), 6M (11.00%)

• 5Y Average Net Profit Margin: 8.43%

• Dividend Yield: 0.10%

• 5Y CAGR: 8.43%

• Sector: Renewable Energy

JSW Energy Ltd

JSW Energy is a major power generation company focusing on both thermal and renewable energy sources. The company operates significant plants including Baspa (300 MW), Karcham Wangtoo (1091 MW) and facilities in Barmer, Vijaynagar and Ratnagiri, demonstrating its diverse power generation portfolio.

• Market Cap: ₹97,296.75 Cr

• Current Share Price: ₹557.55

• Returns: 1Y (14.98%), 1M (-14.31%), 6M (-21.45%)

• 5Y Average Net Profit Margin: 14.12%

• Dividend Yield: 0.34%

• 5Y CAGR: 14.12%

• Sector: Power Generation

Tata Power Company Ltd

Tata Power is India’s largest integrated power company, engaged in generation, transmission and distribution of electricity. The company operates across multiple segments including thermal, renewable energy and power distribution, while also providing project management services, infrastructure management and trading services through its extensive network.

• Market Cap: ₹116,917.47 Cr

• Current Share Price: ₹365.9

• Returns: 1Y (5.69%), 1M (-7.41%), 6M (-13.71%)

• 5Y Average Net Profit Margin: 4.30%

• Dividend Yield: 0.55%

• 5Y CAGR: 4.30%

• Sector: Power Transmission & Distribution

NHPC Ltd

NHPC is India’s premier hydropower company, currently constructing eight hydro projects with 6,434 MW capacity. The company operates multiple power stations including Salal, Dulhasti and Kishanganga, while also providing comprehensive consultancy services for hydropower project development, operation and modernization.

• Market Cap: ₹79,375.87 Cr

• Current Share Price: ₹79.02

• Returns: 1Y (4.04%), 1M (-3.11%), 6M (-26.36%)

• 5Y Average Net Profit Margin: 31.23%

• Dividend Yield: 2.40%

• 5Y CAGR: 31.23%

• Sector: Renewable Energy

SJVN Ltd

SJVN is a diversified power company engaged in hydro, thermal, wind and solar power generation. The company has expanded into wind power with projects like the 47.6 MW Khirvire Wind Power Project and 50 MW Sadla Wind Power Project, along with operating 81.3 MW of solar projects.

• Market Cap: ₹38,865.67 Cr

• Current Share Price: ₹98.9

• Returns: 1Y (-4.81%), 1M (-9.62%), 6M (-31.41%)

• 5Y Average Net Profit Margin: 41.40%

• Dividend Yield: 1.82%

• 5Y CAGR: 41.40%

• Sector: Renewable Energy

Orient Green Power Company Ltd

Orient Green Power specializes in renewable energy generation, primarily wind energy. The company manages a substantial portfolio of 402.3 MW wind assets distributed across Tamil Nadu, Andhra Pradesh, Gujarat and Karnataka in India, along with a 10.5 MW wind farm in Croatia, demonstrating its international presence.

• Market Cap: ₹1,885.06 Cr

• Current Share Price: ₹16.07

• Returns: 1Y (-21.08%), 1M (-4.57%), 6M (-15.05%)

• 5Y Average Net Profit Margin: 3.63%

• 5Y CAGR: 3.63%

• Sector: Renewable Energy

Adani Green Energy Ltd

Adani Green Energy is a major renewable power generation company developing, building and operating utility-scale grid-connected solar, wind and hybrid projects across India. With operations in 91 locations spanning multiple states, the company sells power through long-term PPAs and merchant arrangements.

• Market Cap: ₹165,642.28 Cr

• Current Share Price: ₹1,045.7

• Returns: 1Y (-37.79%), 1M (1.00%), 6M (-39.04%)

• 5Y Average Net Profit Margin: 7.01%

• 5Y CAGR: 7.01%

• Sector: Renewable Energy

Fundamental Analysis Of Pharma Sector

Divi’s Laboratories Ltd

Divi’s Labs has established itself as a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates since its founding. The company specializes in custom synthesis for global pharma companies, supporting both generic and patented products from clinical trials to commercial scale. Their comprehensive capabilities in APIs and nutraceuticals have made them a preferred partner for pharmaceutical companies worldwide.

• Market Cap: ₹154,473.51 Cr

• Current Share Price: ₹5,818.9

• Returns: 1Y (60.95%), 1M (2.30%), 6M (28.32%)

• 5Y Average Net Profit Margin: 25.51%

• Dividend Yield: 0.52%

• 5Y CAGR: 25.51%

• Sector: Labs & Life Sciences Services

Lupin Ltd

Founded in 1968, Lupin has grown into a global pharmaceutical powerhouse with a strong presence in generics, biotechnology and APIs. The company excels in multiple therapeutic segments including cardiovascular, diabetology and respiratory care. With manufacturing facilities across India, USA, Mexico and Brazil, Lupin has established a robust global presence.

• Market Cap: ₹96,003.15 Cr

• Current Share Price: ₹2,104.25

• Returns: 1Y (46.20%), 1M (-0.82%), 6M (16.56%)

• 5Y Average Net Profit Margin: 1.83%

• Dividend Yield: 0.38%

• 5Y CAGR: 1.83%

• Sector: Pharmaceuticals

Zydus Lifesciences Ltd

Zydus has evolved into an innovative life sciences company with particular strength in speciality formulations and biosimilars. Their research focus has led to breakthrough developments like Bilypsa for NAFLD/NASH treatment and India’s first DNA vaccine for COVID-19 (ZyCoV-D), demonstrating their commitment to novel therapeutic solutions.

• Market Cap: ₹99,204.61 Cr

• Current Share Price: ₹985.9

• Returns: 1Y (36.53%), 1M (2.26%), 6M (-14.61%)

• 5Y Average Net Profit Margin: 15.80%

• Dividend Yield: 0.30%

• 5Y CAGR: 15.80%

• Sector: Pharmaceuticals

Sun Pharmaceutical Industries Ltd

Sun Pharma stands as India’s largest pharmaceutical company, having grown from a small distribution business to a global specialty generic pharmaceutical leader. Their comprehensive portfolio spans generic and specialty medicines, with significant investments in research and development leading to innovative products across therapeutic areas.

• Market Cap: ₹422,930.78 Cr

• Current Share Price: ₹1,762.7

• Returns: 1Y (27.89%), 1M (-1.85%), 6M (11.05%)

• 5Y Average Net Profit Margin: 13.23%

• Dividend Yield: 0.77%

• 5Y CAGR: 13.23%

• Sector: Pharmaceuticals

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals has built strong expertise in therapeutic segments like cardiovascular, CNS and gastrointestinal medicines. With manufacturing facilities across five Indian states and a robust distribution network, they’ve established themselves as a significant player in both domestic and international markets.

• Market Cap: ₹106,823.53 Cr

• Current Share Price: ₹3,156.3

• Returns: 1Y (26.91%), 1M (-8.52%), 6M (4.18%)

• 5Y Average Net Profit Margin: 13.06%

• Dividend Yield: 0.89%

• 5Y CAGR: 13.06%

• Sector: Pharmaceuticals

Mankind Pharma Ltd

Mankind Pharma has grown from its foundation into one of India’s leading pharmaceutical companies by focusing on affordable healthcare solutions. The company’s diverse portfolio spans acute and chronic therapeutic areas, with particular strength in anti-infectives, cardiovascular and gastrointestinal medicines. Their success stems from deep market penetration and strong brand recognition in both urban and rural markets.

• Market Cap: ₹105,763.59 Cr

• Current Share Price: ₹2,563.55

• Returns: 1Y (19.63%), 1M (-5.45%), 6M (21.59%)

• 5Y Average Net Profit Margin: 17.47%

• Dividend Yield: 0%

• 5Y CAGR: 17.47%

• Sector: Pharmaceuticals

Dr. Reddy’s Laboratories Ltd

Dr. Reddy’s has evolved from its inception into a fully integrated pharmaceutical company with global reach. Their business model spans the entire pharmaceutical value chain, from APIs to complex generics and biosimilars. Their strategic focus on difficult-to-manufacture products and investment in research and development has established them as a leader in multiple therapeutic areas.

• Market Cap: ₹107,313.89 Cr

• Current Share Price: ₹1,288.15

• Returns: 1Y (13.51%), 1M (-4.03%), 6M (-4.88%)

• 5Y Average Net Profit Margin: 13.57%

• Dividend Yield: 0.62%

• 5Y CAGR: 13.57%

• Sector: Pharmaceuticals

Alkem Laboratories Ltd

Alkem Laboratories has built its reputation through excellence in pharmaceutical manufacturing and research. Operating 21 manufacturing facilities across India and the United States, they’ve developed a portfolio of 800 brands across diverse therapeutic areas. Their success is built on strong research capabilities and a robust distribution network reaching 40 countries.

• Market Cap: ₹61,902.39 Cr

• Current Share Price: ₹5,177.3

• Returns: 1Y (7.51%), 1M (-3.96%), 6M (-0.76%)

• 5Y Average Net Profit Margin: 13.63%

• Dividend Yield: 0.77%

• 5Y CAGR: 13.63%

• Sector: Pharmaceuticals

Aurobindo Pharma Ltd

Aurobindo Pharma has transformed itself into a global pharmaceutical company with operations in 150 countries. The company’s strength lies in its integrated approach, manufacturing both APIs and finished formulations across seven major therapeutic areas. Their strategic focus on complex products like oncology, hormones and microsphere-based depot injections demonstrates their commitment to high-value pharmaceutical development.

• Market Cap: ₹68,941.15 Cr

• Current Share Price: ₹1,187

• Returns: 1Y (4.71%), 1M (-4.63%), 6M (-11.72%)

• 5Y Average Net Profit Margin: 12.10%

• Dividend Yield: 0.38%

• 5Y CAGR: 12.10%

• Sector: Pharmaceuticals

Cipla Ltd

Cipla stands as one of India’s oldest and most respected pharmaceutical companies, with a rich heritage dating back to 1935. The company operates 47 manufacturing sites globally and has pioneered affordable healthcare solutions, particularly in respiratory medicine and HIV/AIDS treatment. Their recent focus on complex generics and biosimilars shows their evolution toward higher-value pharmaceutical segments.

• Market Cap: ₹115,327.28 Cr

• Current Share Price: ₹1,428

• Returns: 1Y (1.35%), 1M (-2.26%), 6M (-4.16%)

• 5Y Average Net Profit Margin: 12.05%

• Dividend Yield: 0.91%

• 5Y CAGR: 12.05%

• Sector: Pharmaceuticals

Green Energy Sector Performance & Growth

The below table shows the Green Energy Sector Performance & Growth based on 5 Year Net Profit Margin.

Name	Close Price (rs)	5Y Avg Net Profit Margin (%)
SJVN Ltd	98.90	41.40
NHPC Ltd	79.02	31.23
JSW Energy Ltd	557.55	14.12
K.P. Energy Ltd	456.35	8.43
Adani Green Energy Ltd	1045.70	7.01
Tata Power Company Ltd	365.90	4.30
Orient Green Power Company Ltd	16.07	3.63
Waaree Renewable Technologies Ltd	1015.95	-4.14
Suzlon Energy Ltd	57.43	-9.16
Inox Wind Ltd	165.57	-48.96

Pharmaceutical Sector Performance & Growth

The below table shows the Pharmaceutical Sector’s Performance & Growth based on 5 Year Net Profit Margin.

Name	Close Price (rs)	5Y Avg Net Profit Margin (%)
Divi’s Laboratories Ltd	5818.90	25.51
Mankind Pharma Ltd	2563.55	17.47
Zydus Lifesciences Ltd	985.90	15.80
Alkem Laboratories Ltd	5177.30	13.63
Dr Reddy’s Laboratories Ltd	1288.15	13.57
Sun Pharmaceutical Industries Ltd	1762.70	13.23
Torrent Pharmaceuticals Ltd	3156.30	13.06
Aurobindo Pharma Ltd	1187.00	12.10
Cipla Ltd	1428.00	12.05
Lupin Ltd	2104.25	1.83

Government Policies & Incentives For The Green Energy and Pharma Sector

The government supports green energy and pharma sectors through subsidies, tax incentives and production-linked incentives (PLI), fostering renewable energy adoption, pharmaceutical manufacturing and R&D advancements to enhance sustainability and healthcare innovation.

Initiatives like PLI for pharma, renewable energy targets and infrastructure grants drive domestic drug production, clean energy investments and technology advancements, ensuring energy security, reduced emissions and strengthened pharmaceutical self-reliance for long-term economic and healthcare growth.

Challenges Faced By the Green Energy and Pharma Sector

The main challenges in both sectors include intensive research demands, strict regulatory compliance, quality manufacturing processes and high market competition, affecting overall growth, innovation capabilities and operational efficiency.

• Research Requirements: Both sectors demand significant investment in R&D, with continuous innovation needs and long development cycles impacting cost structures and market competitiveness.

• Regulatory Compliance: Complex regulatory frameworks require strict adherence to quality standards, documentation requirements and operational protocols affecting time-to-market and cost structures.

Future Outlook Of Green Energy and Pharma Sector

Both sectors demonstrate strong growth potential through essential market needs. Green energy expands through environmental imperatives and technological advancement, while pharma grows through healthcare demands and research breakthroughs.

These sectors address fundamental human needs in environmental sustainability and healthcare, supported by increasing research capabilities, technological innovation and growing market opportunities.

How to invest in the Green Energy and Pharma Sector Stocks?

Start by opening a demat account with Alice Blue, researching companies thoroughly across both sectors. Focus on research capabilities, innovation potential, regulatory compliance and market positioning while understanding sector dynamics.

Monitor policy developments, research breakthroughs and market trends while maintaining systematic investment approach. Consider long-term growth potential and the essential nature of both sectors in portfolio allocation.

Difference Between Pharma Sector And Green Energy Sector – Conclusion

• The main difference between the green energy and pharma sectors is that green energy focuses on renewable power solutions for environmental sustainability, while pharma specializes in drug development and healthcare advancements to improve human health and wellness.

• The green energy sector includes companies developing solar, wind and hydroelectric power, advancing technology for sustainability. Investments in research, innovation and efficiency improvements drive reduced carbon emissions and energy independence through sustainable power generation.

• The pharmaceutical sector involves drug research, development and distribution, ensuring safe and effective healthcare products. Continuous innovation, strict regulatory compliance and advanced manufacturing processes support medical advancements, addressing global health concerns with scientific solutions.

• Governments support green energy and pharma through incentives like PLI, tax benefits and infrastructure grants. These measures boost renewable energy adoption, pharmaceutical manufacturing and research advancements, strengthening economic growth, energy security and healthcare innovation.

• The main challenges include research intensity, regulatory compliance, manufacturing quality and market competition affecting both sectors’ growth and operational efficiency.

• Both sectors show strong growth potential-green energy through technological progress and environmental policies and pharma through healthcare demand and research breakthroughs. Increasing market opportunities and innovation drive expansion in sustainability and medical advancements.

• To invest, open a demat account with Alice Blue, research company fundamentals, monitor policies and track sector trends. Prioritize innovation, regulatory compliance and market positioning, ensuring a systematic long-term investment approach for balanced portfolio allocation.

Green Energy Sector Vs Pharma Sector – FAQs

Disclaimer: The above article is written for educational purposes and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.